Handelsbanken Fonder’s LeMaitre Vascular LMAT Stock Holding History

Handelsbanken Fonder’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$806K	Buy	+8,400	New	+$861K	﹤0.01%	1227

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Handelsbanken Fonder's LMAT Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 8,400 shares worth $806K. The stake represents ﹤0.01% of the portfolio and ranks #1227 among its holdings.

326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Handelsbanken Fonder held 8,400 shares of LeMaitre Vascular worth $806K as of Q2 2026.
LeMaitre Vascular was a new Handelsbanken Fonder position in Q2 2026.
LeMaitre Vascular made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1227 holding.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.